The immunogloblin nature of nephritic factor (NeF)
Abstract
NeF was shown to be antigenically and structurally similar to IgG by the following experiments: (1) NeF activity in serum was absorbed by and, under acid conditions, could be eluted from (a) anti-myeloma IgG antibody coupled to Sepharose and (b) protein A-Sepharose. (2) Purified NeF could bind to anit-myeloma IgG-Sepharose and could be eluted with acid, and this binding was blocked by myeloma IgG. (3) An antibody to beta2, microglobulin, showing strong cross-reactivity with normal IgG, bound NeF activity before, but not after, absorption of the antiserum with IgG. (4) Sepharose-coupled antibodies to NeF could bind activity which was recovered in the acid eluate. This binding capacity was lost after absorption of the antibody with normal and myeloma IgG. (5) Structural similarity was demonstrated by pepsin and papain digestion, which resulted in NeF activity eluting with F(ab')2 and Fab fragments from protein A-Sepharose and Sephadex G-150. (6) Autoradiography of PAGE-SDS of 125I-labelled NeF eluted from EA43bBb cells showed that NeF had a larger H chain than normal IgG, suggesting that NeF might be an abnormal IgG molecule.
Similar articles
-
The role of carbohydrate in the structure and function of nephritic factor.Clin Exp Immunol. 1981 Oct;46(1):120-9. Clin Exp Immunol. 1981. PMID: 6802534 Free PMC article.
-
Further evidence for the antibody nature of C3 nephritic factor (C3NeF).J Immunol. 1979 Aug;123(2):755-8. J Immunol. 1979. PMID: 379217
-
Antiidiotypic activity in the IgM fractions of mixed cryoglobulins.J Immunol. 1980 Oct;125(4):1530-5. J Immunol. 1980. PMID: 6774023
-
The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.J Immunol. 1981 Jan;126(1):7-10. J Immunol. 1981. PMID: 6778918
-
Identification of nephritic factor as an immunoglobulin.Clin Exp Immunol. 1978 Sep;33(3):425-9. Clin Exp Immunol. 1978. PMID: 104814 Free PMC article.
Cited by
-
Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.Immunology. 1989 Dec;68(4):449-52. Immunology. 1989. PMID: 2481642 Free PMC article.
-
Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.Clin Exp Immunol. 1986 Jul;65(1):73-9. Clin Exp Immunol. 1986. PMID: 3641694 Free PMC article.
-
C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.Clin Exp Immunol. 1986 Aug;65(2):450-7. Clin Exp Immunol. 1986. PMID: 3641695 Free PMC article.
-
Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis.J Exp Med. 1992 Apr 1;175(4):939-50. doi: 10.1084/jem.175.4.939. J Exp Med. 1992. PMID: 1532415 Free PMC article.
-
The role of antibody in the activation of the alternative complement pathway.Springer Semin Immunopathol. 1983;6(4):361-71. doi: 10.1007/BF02116280. Springer Semin Immunopathol. 1983. PMID: 6364431 Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources